Cancer news and cancer widget

A team of scientists at Arkansas Nanotechnology Center at UALR (the University of Arkansas at Little Rock) has developed what promises to be a non-invasive method of eradicating cancer cells while reducing the life-threatening side effects of chemotherapy and radiation. The new technique, described in the current issue of the journal Nanotechnology, was developed by a team led by Dr.

Faculty members of the Indiana University School of medicine have been awarded research grants from Susan G. Komen for the Cure. John Foley, Ph.D., David Gilley, Ph.D., and Hiromi Tanaka, Ph.D., are among recipients of an unprecedented $100 million in grants Komen awarded to American and international scientists. Dr.

Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced results of a series of studies demonstrating Protectan CBLB612's ability to substantially reduce myelosuppression (the most common rate limiting adverse effect of chemotherapy) caused by a widely used chemotherapeutic drug, cyclophosphamide (Cytoxan, Neosar, CTX). Michael Fonstein, Ph.D.

#7720 patients' HOME PHOTOS HELP IDENTIFY ASTHMA TRIGGERS The use of in-home photography may be a more cost-effective alternative to in-home inspections for identifying asthma and allergy triggers. Researchers from Truman Medical Center and the University of Missouri, Kansas City, MO, selected 50 adult subjects with persistent asthma to take photos of a predetermined list of areas in their home using a disposable camera.

Skewed X Inactivation in BRCA1 Mutation Carriers One X chromosome is more frequently silenced than the other X chromosome in women who carry mutations in the BRCA1 gene, and the skewed X inactivation is associated with a later onset of breast or ovarian cancer in these women. Each cell in a woman's body carries two X chromosomes, while those of a man carry only one X chromosome.

There is new hope for women around the world, with the launch of an early detection test for ovarian cancer. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlexT Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample. Two Victorian women have become the first test recipients.

University of Pennsylvania School of medicine researchers have discovered how the expression of the Sonic hedgehog gene is regulated during brain development and how mutations that alter this process cause brain malformations. The results appear online this month in Nature Genetics. Sonic hedgehog (Shh) plays a key role in regulating many aspects of embryonic development including, growth of digits on limbs and organization of neurons in the brain.

HealthDay - WEDNESDAY, Oct. 29 (HealthDay News) -- What if a blood test or biopsy could predict if a cancer therapy will help cure you, or only make you feel worse?

Each year, some 29,000 adults and 2,000 children are diagnosed with leukemia, a form of cancer that is caused by the abnormal production of white blood cells in the bone marrow. Current treatments rely primarily on killing the cancer cells, which also destroys normal cells. But what if a way could be found to reprogram cancerous cells back into normal cells? A team of Syracuse University researchers believes it may have found a way to do just that.

(Thomas Jefferson University) Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry.